Synergistic antibacterial effects of magnolia bark extract and L-arginine, N-alpha-lauroyl ethyl ester on plaque biofilm
The present disclosure relates generally to oral compositions and methods for inhibiting the formation of plaque biofilm by salivary bacteria, and more particularly, to oral compositions comprising a combination of magnolia bark extract (MBE) and L-arginine, N.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 23. Dez. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
TIAN MINMIN [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-12-23, Last update posted on www.tib.eu: 2022-10-24, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
AU2016321396 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA010416587 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA010416587 | ||
| 003 | DE-627 | ||
| 005 | 20230504063125.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210531s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA010416587 | ||
| 035 | |a (EPA)AU2016321396 | ||
| 035 | |a (EPA)57104180 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a TIAN MINMIN |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Synergistic antibacterial effects of magnolia bark extract and L-arginine, N-alpha-lauroyl ethyl ester on plaque biofilm |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-12-23, Last update posted on www.tib.eu: 2022-10-24, Last updated: 2023-02-09 | ||
| 520 | |a The present disclosure relates generally to oral compositions and methods for inhibiting the formation of plaque biofilm by salivary bacteria, and more particularly, to oral compositions comprising a combination of magnolia bark extract (MBE) and L-arginine, N | ||
| 650 | 4 | |a A61Q: Specific use of cosmetics or similar toilet preparations | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A23G: Cocoa; cocoa products, e.g. chocolate; substitutes for cocoa or cocoa products; confectionery; chewing gum; ice-cream; preparation thereof | |
| 650 | 4 | |a tec | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a DODDS MICHAEL W |4 aut | |
| 700 | 0 | |a INUI TAICHI |4 aut | |
| 700 | 0 | |a RAMIREZ LILIAN |4 aut | |
| 700 | 0 | |a ASPIRAS MARCELO B |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 23. Dez. |
| 773 | 1 | 8 | |g year:2021 |g day:23 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/57104180/publication/AU2016321396A1?q=AU2016321396 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2021 |b 23 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 23 |c 12 | ||